Advanced search
Publication Cover
Emerging Microbes & Infections Volume 3, 2014 - Issue 1
Submit an article Journal homepage
1,110
Views
45
CrossRef citations to date
0
Altmetric
Original Articles

The Rift Valley fever accessory proteins NSm and P78/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts

Felix KreherMolecular Genetics of Bunyaviruses, Institut Pasteur, F-75015 Paris, France;Structural Virology, Institut Pasteur, F-75015 Paris, France;Univ Paris Diderot, Sorbonne Paris Cité, F-75205 Paris, France
,
Carole TamiettiMolecular Genetics of Bunyaviruses, Institut Pasteur, F-75015 Paris, France;Structural Virology, Institut Pasteur, F-75015 Paris, France
,
Céline GommetMouse Functional Genetics, Institut Pasteur, F-75015 Paris, France;CNRS URA 2578, Institut Pasteur, F-75015 Paris, France;Central Animal Facilities, Institut Pasteur, F-75015 Paris, France
,
Laurent GuillemotMouse Functional Genetics, Institut Pasteur, F-75015 Paris, France;CNRS URA 2578, Institut Pasteur, F-75015 Paris, France
,
Myriam ErmonvalMolecular Genetics of Bunyaviruses, Institut Pasteur, F-75015 Paris, France
,
Anna-Bella FaillouxArboviruses and Insect Vectors, Institut Pasteur, F-75015 Paris, France
,
Jean-Jacques PanthierMouse Functional Genetics, Institut Pasteur, F-75015 Paris, France;CNRS URA 2578, Institut Pasteur, F-75015 Paris, France
,
Michèle BouloyMolecular Genetics of Bunyaviruses, Institut Pasteur, F-75015 Paris, France
&
Marie FlamandMolecular Genetics of Bunyaviruses, Institut Pasteur, F-75015 Paris, France;Structural Virology, Institut Pasteur, F-75015 Paris, FranceCorrespondence[email protected]
 show all
Pages 1-12 | Received 23 Sep 2015, Accepted 02 Nov 2015, Published online: 25 Jan 2019

Citations (45)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Tetsuro Ikegami. (2017) Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate. Expert Review of Vaccines 16:6, pages 601-611.
Read now
Psylvia Léger & Pierre-Yves Lozach. (2015) Bunyaviruses: From Transmission by Arthropods to Virus Entry into the Mammalian Host First-Target Cells. Future Virology 10:7, pages 859-881.
Read now

Articles from other publishers (43)

Linus Bostedt, Lucie Fénéant, Anne Leske, Julia Holzerland, Karla Günther, Irke Waßmann, Patrick Bohn & Allison Groseth. (2024) Alternative translation contributes to the generation of a cytoplasmic subpopulation of the Junín virus nucleoprotein that inhibits caspase activation and innate immunity. Journal of Virology 98:2.
Crossref
Sandra Moreno, Gema Lorenzo, Álvaro López-Valiñas, Nuria de la Losa, Celia Alonso, Elena Charro, José I. Núñez, Pedro J. Sánchez-Cordón, Belén Borrego & Alejandro Brun. (2024) Safety and Efficacy upon Infection in Sheep with Rift Valley Fever Virus ZH548-rA2, a Triple Mutant Rescued Virus. Viruses 16:1, pages 87.
Crossref
Cigdem Alkan, Eduardo Jurado-Cobena & Tetsuro Ikegami. (2023) Advancements in Rift Valley fever vaccines: a historical overview and prospects for next generation candidates. npj Vaccines 8:1.
Crossref
Niranjana Nair, Albert D. M. E. Osterhaus, Guus F. Rimmelzwaan & Chittappen Kandiyil Prajeeth. (2023) Rift Valley Fever Virus—Infection, Pathogenesis and Host Immune Responses. Pathogens 12:9, pages 1174.
Crossref
Jake Barker, Luis L. P. daSilva & Colin M. Crump. (2023) Mechanisms of bunyavirus morphogenesis and egress. Journal of General Virology 104:4.
Crossref
Mathilde Laureti, Rui-Xue Lee, Amelia Bennett, Lucas Aladar Wilson, Victoria Elena Sy, Alain Kohl & Isabelle Dietrich. (2023) Rift Valley Fever Virus Primes Immune Responses in Aedes aegypti Cells. Pathogens 12:4, pages 563.
Crossref
Paul J. Wichgers Schreur, Brian H. Bird, Tetsuro Ikegami, Erick Bermúdez-Méndez & Jeroen Kortekaas. (2023) Perspectives of Next-Generation Live-Attenuated Rift Valley Fever Vaccines for Animal and Human Use. Vaccines 11:3, pages 707.
Crossref
Meng Hao, Ting Bian, Guangcheng Fu, Yi Chen, Ting Fang, Chuanyi Zhao, Shuling Liu, Changming Yu, Jianmin Li & Wei Chen. (2023) An adenovirus-vectored RVF vaccine confers complete protection against lethal RVFV challenge in A129 mice. Frontiers in Microbiology 14.
Crossref
Xiao Wang, Yupei Yuan, Yihan Liu & Leiliang Zhang. (2022) Arm race between Rift Valley fever virus and host. Frontiers in Immunology 13.
Crossref
Tetsuro Ikegami, Eduardo Jurado-Cobena, Cigdem Alkan, Jennifer K. Smith, Lihong Zhang, Birte Kalveram, Terry L. Juelich, Allen T. Esterly, Jahnavi R. Bhaskar, Saravanan Thangamani & Alexander N. Freiberg. (2022) Evaluations of rationally designed rift valley fever vaccine candidate RVax-1 in mosquito and rodent models. npj Vaccines 7:1.
Crossref
Paul J. Wichgers Schreur, Petra Mooij, Gerrit Koopman, Babs E. Verstrepen, Zahra Fagrouch, Daniella Mortier, Nikki van Driel, Jet Kant, Sandra van de Water, Willy M. Bogers, Carine Punt, Lucien van Keulen, Ernst J. Verschoor & Jeroen Kortekaas. (2022) Safety and immunogenicity of four-segmented Rift Valley fever virus in the common marmoset. npj Vaccines 7:1.
Crossref
Nicole Bracci, Cynthia de la Fuente, Sahar Saleem, Chelsea Pinkham, Aarthi Narayanan, Adolfo García-Sastre, Velmurugan Balaraman, Juergen A. Richt, William Wilson & Kylene Kehn-Hall. (2022) Rift Valley fever virus Gn V5-epitope tagged virus enables identification of UBR4 as a Gn interacting protein that facilitates Rift Valley fever virus production. Virology 567, pages 65-76.
Crossref
Pablo Guardado-Calvo & Félix A. Rey. (2021) The Viral Class II Membrane Fusion Machinery: Divergent Evolution from an Ancestral Heterodimer. Viruses 13:12, pages 2368.
Crossref
Baptiste Dungu & Michèle Bouloy. 2021. Veterinary Vaccines. Veterinary Vaccines 253 262 .
Psylvia Léger & Pierre-Yves Lozach. (2021) Le virus de la fièvre de la vallée du Rift et son étonnante protéine NSs. médecine/sciences 37:6-7, pages 601-608.
Crossref
K. M. Gregor, L. M. Michaely, B. Gutjahr, M. Rissmann, M. Keller, S. Dornbusch, F. Naccache, K. Schön, S. Jansen, A. Heitmann, R. König, B. Brennan, R. M. Elliott, S. Becker, M. Eiden, I. Spitzbarth, W. Baumgärtner, C. Puff, R. Ulrich & M. H. Groschup. (2021) Rift Valley fever virus detection in susceptible hosts with special emphasis in insects. Scientific Reports 11:1.
Crossref
Lieza Odendaal, A Sally Davis & Estelle H Venter. (2021) Insights into the Pathogenesis of Viral Haemorrhagic Fever Based on Virus Tropism and Tissue Lesions of Natural Rift Valley Fever. Viruses 13:4, pages 709.
Crossref
Belén Borrego, Sandra Moreno, Nuria de la Losa, Friedemann Weber & Alejandro Brun. (2021) The Change P82L in the Rift Valley Fever Virus NSs Protein Confers Attenuation in Mice. Viruses 13:4, pages 542.
Crossref
Paul J. Wichgers Schreur, Mirriam Tacken, Benjamin Gutjahr, Markus Keller, Lucien van Keulen, Jet Kant, Sandra van de Water, Yanyin Lin, Martin Eiden, Melanie Rissmann, Felicitas von Arnim, Rebecca König, Alexander Brix, Catherine Charreyre, Jean-Christophe Audonnet, Martin H. Groschup & Jeroen Kortekaas. (2021) Vaccine Efficacy of Self-Assembled Multimeric Protein Scaffold Particles Displaying the Glycoprotein Gn Head Domain of Rift Valley Fever Virus. Vaccines 9:3, pages 301.
Crossref
Tetsuro Ikegami. (2021) Development of a Simian RNA Polymerase I Promoter-Driven Reverse Genetics System for the Rescue of Recombinant Rift Valley Fever Virus from Vero Cells. Journal of Virology 95:7.
Crossref
Ruben J. G. Hulswit, Guido C. Paesen, Thomas A. Bowden & Xiaohong Shi. (2021) Recent Advances in Bunyavirus Glycoprotein Research: Precursor Processing, Receptor Binding and Structure. Viruses 13:2, pages 353.
Crossref
Shanna S. Leventhal, Drew Wilson, Heinz Feldmann & David W. Hawman. (2021) A Look into Bunyavirales Genomes: Functions of Non-Structural (NS) Proteins. Viruses 13:2, pages 314.
Crossref
Belén Borrego & Alejandro Brun. (2021) A Hyper-Attenuated Variant of Rift Valley Fever Virus Generated by a Mutagenic Drug (Favipiravir) Unveils Potential Virulence Markers. Frontiers in Microbiology 11.
Crossref
Aline Bamia, Vasco Marcato, Magali Boissière, Zeyni Mansuroglu, Carole Tamietti, Mattea Romani, Dominique Simon, Guanfang Tian, Florence Niedergang, Jean-Jacques Panthier, Marie Flamand, Sylvie Souès & Eliette Bonnefoy. (2020) The NSs Protein Encoded by the Virulent Strain of Rift Valley Fever Virus Targets the Expression of Abl2 and the Actin Cytoskeleton of the Host, Affecting Cell Mobility, Cell Shape, and Cell-Cell Adhesion. Journal of Virology 95:1.
Crossref
Elysse N. Grossi-Soyster & A. Desiree LaBeaud. (2020) Rift Valley Fever: Important Considerations for Risk Mitigation and Future Outbreaks. Tropical Medicine and Infectious Disease 5:2, pages 89.
Crossref
Andrea Louise Kroeker, Shawn Babiuk, Bradley S. Pickering, Juergen A. Richt & William C. Wilson. (2020) Livestock Challenge Models of Rift Valley Fever for Agricultural Vaccine Testing. Frontiers in Veterinary Science 7.
Crossref
Leandro Batista, Gregory Jouvion, Dominique Simon-Chazottes, Denis Houzelstein, Odile Burlen-Defranoux, Magali Boissière, Satoko Tokuda, Tania Zaverucha do Valle, Ana Cumano, Marie Flamand, Xavier Montagutelli & Jean-Jacques Panthier. (2020) Genetic dissection of Rift Valley fever pathogenesis: Rvfs2 locus on mouse chromosome 11 enables survival to early-onset hepatitis. Scientific Reports 10:1.
Crossref
Juan Gonzalez-Valdivieso, Belen Borrego, Alessandra Girotti, Sandra Moreno, Alejandro Brun, Jesus F. Bermejo-Martin & F. Javier Arias. (2020) A DNA Vaccine Delivery Platform Based on Elastin-Like Recombinamer Nanosystems for Rift Valley Fever Virus. Molecular Pharmaceutics 17:5, pages 1608-1620.
Crossref
Daniel Wright, Jeroen Kortekaas, Thomas A. Bowden & George M. Warimwe. (2019) Rift Valley fever: biology and epidemiology. Journal of General Virology 100:8, pages 1187-1199.
Crossref
Sebastiaan ter Horst, Nádia Conceição‐Neto, Johan Neyts & Joana Rocha‐Pereira. (2019) Structural and functional similarities in bunyaviruses: Perspectives for pan‐bunya antivirals. Reviews in Medical Virology 29:3.
Crossref
Natasha N. Gaudreault, Sabarish V. Indran, Velmurugan Balaraman, William C. Wilson & Juergen A. Richt. (2018) Molecular aspects of Rift Valley fever virus and the emergence of reassortants. Virus Genes 55:1, pages 1-11.
Crossref
Gema Lorenzo, Elena López-Gil, Javier Ortego & Alejandro Brun. (2018) Efficacy of different DNA and MVA prime-boost vaccination regimens against a Rift Valley fever virus (RVFV) challenge in sheep 12 weeks following vaccination. Veterinary Research 49:1.
Crossref
Claudia Mroz, Kristina M. Schmidt, Sven Reiche, Martin H. Groschup & Martin Eiden. (2018) Development of monoclonal antibodies to Rift Valley Fever Virus and their application in antigen detection and indirect immunofluorescence. Journal of Immunological Methods 460, pages 36-44.
Crossref
Isabelle Dietrich, Stephanie Jansen, Gamou Fall, Stephan Lorenzen, Martin Rudolf, Katrin Huber, Anna Heitmann, Sabine Schicht, El Hadji Ndiaye, Mick Watson, Ilaria Castelli, Benjamin Brennan, Richard M. Elliott, Mawlouth Diallo, Amadou A. Sall, Anna-Bella Failloux, Esther Schnettler, Alain Kohl & Stefanie C. Becker. (2017) RNA Interference Restricts Rift Valley Fever Virus in Multiple Insect Systems. mSphere 2:3.
Crossref
Paul J. Wichgers Schreur, Lucien van Keulen, Jet Kant & Jeroen Kortekaas. (2017) Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy. Vaccine 35:23, pages 3123-3128.
Crossref
Pablo Guardado-Calvo & Félix A. Rey. 2017. 83 118 .
Hoai J. Ly & Tetsuro Ikegami. (2016) Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins. Virology Journal 13:1.
Crossref
Martin Spiegel, Teresa Plegge & Stefan Pöhlmann. (2016) The Role of Phlebovirus Glycoproteins in Viral Entry, Assembly and Release. Viruses 8:7, pages 202.
Crossref
Inaia Phoenix, Nandadeva Lokugamage, Shoko Nishiyama & Tetsuro Ikegami. (2016) Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression. Viruses 8:6, pages 151.
Crossref
Inaia Phoenix, Shoko Nishiyama, Nandadeva Lokugamage, Terence Hill, Matthew Huante, Olga Slack, Victor Carpio, Alexander Freiberg & Tetsuro Ikegami. (2016) N-Glycans on the Rift Valley Fever Virus Envelope Glycoproteins Gn and Gc Redundantly Support Viral Infection via DC-SIGN. Viruses 8:5, pages 149.
Crossref
Jody Hobson-Peters, David Warrilow, Breeanna J McLean, Daniel Watterson, Agathe M.G. Colmant, Andrew F. van den Hurk, Sonja Hall-Mendelin, Marcus L. Hastie, Jeffrey J. Gorman, Jessica J. Harrison, Natalie A. Prow, Ross T. Barnard, Richard Allcock, Cheryl A. Johansen & Roy A. Hall. (2016) Discovery and characterisation of a new insect-specific bunyavirus from Culex mosquitoes captured in northern Australia. Virology 489, pages 269-281.
Crossref
Shoko Nishiyama & Tetsuro Ikegami. (2015) Temperature-sensitive mutations for live-attenuated Rift Valley fever vaccines: implications from other RNA viruses. Frontiers in Microbiology 6.
Crossref
Kaori Terasaki & Shinji Makino. (2015) Interplay between the Virus and Host in Rift Valley Fever Pathogenesis. Journal of Innate Immunity 7:5, pages 450-458.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.